https://www.kaziatx.com/media-center/in-the-news/rss en-us https://s3.amazonaws.com/equisolve-dev4/kaziatherapeutics/files/theme/images/logo-sm.png https://www.kaziatx.com Equisolve Investor Relations Suite https://podcasts.apple.com/us/podcast/reprogramming-cancer-biology-to-overcome-treatment/id1037463498?i=1000793678954 Wed, 07 Oct 26 00:00:00 -0400 https://podcasts.apple.com/us/podcast/reprogramming-cancer-biology-to-overcome-treatment/id1037463498?i=1000793678954 https://open.spotify.com/episode/6amLqvWXlAa2VRlX8HBKPH?si=dcePTpVVSEKyQIACMtNG-A&nd=1&dlsi=b2d216b660444af0 Wed, 30 Sep 26 00:00:00 -0400 https://open.spotify.com/episode/6amLqvWXlAa2VRlX8HBKPH?si=dcePTpVVSEKyQIACMtNG-A&nd=1&dlsi=b2d216b660444af0 https://www.curetoday.com/view/how-paxalisib-is-being-studied-in-treatment-resistant-breast-cancer Fri, 25 Sep 26 00:00:00 -0400 https://www.curetoday.com/view/how-paxalisib-is-being-studied-in-treatment-resistant-breast-cancer https://medium.com/authority-magazine/female-disruptors-sudha-rao-of-kazia-therapeutics-on-the-three-things-you-need-to-shake-up-your-d17653450e93 Thu, 24 Sep 26 00:00:00 -0400 https://medium.com/authority-magazine/female-disruptors-sudha-rao-of-kazia-therapeutics-on-the-three-things-you-need-to-shake-up-your-d17653450e93 https://biopharmaapac.com/news/31/8469/sovargen-doses-first-patient-in-phase-ib-iia-trial-of-kazias-paxalisib-for-rare-epilepsies.html Wed, 23 Sep 26 00:00:00 -0400 https://biopharmaapac.com/news/31/8469/sovargen-doses-first-patient-in-phase-ib-iia-trial-of-kazias-paxalisib-for-rare-epilepsies.html https://www.curetoday.com/view/paxalisib-trial-expands-to-hr-positive-her2-negative-breast-cancer Tue, 22 Sep 26 00:00:00 -0400 https://www.curetoday.com/view/paxalisib-trial-expands-to-hr-positive-her2-negative-breast-cancer https://www.curetoday.com/view/how-paxalisib-targets-treatment-resistance-in-breast-cancer Tue, 22 Sep 26 00:00:00 -0400 https://www.curetoday.com/view/how-paxalisib-targets-treatment-resistance-in-breast-cancer https://discover-pharma.com/kazia-paxalisib-triple-negative-breast-cancer/ Mon, 14 Sep 26 00:00:00 -0400 https://discover-pharma.com/kazia-paxalisib-triple-negative-breast-cancer/ https://biopharmaapac.com/news/78/8418/kazia-doses-first-patient-in-phase-ii-study-of-paxalisib-combination-for-aggressive-paediatric-brain-cancer.html Fri, 11 Sep 26 00:00:00 -0400 https://biopharmaapac.com/news/78/8418/kazia-doses-first-patient-in-phase-ii-study-of-paxalisib-combination-for-aggressive-paediatric-brain-cancer.html https://trial.medpath.com/news/kazia-therapeutics-doses-first-patient-in-pnoc035-phase-2-trial-of-paxalisib-plus-gemcitabine-for-recurrent-pediatric-at-rt Wed, 09 Sep 26 00:00:00 -0400 https://trial.medpath.com/news/kazia-therapeutics-doses-first-patient-in-pnoc035-phase-2-trial-of-paxalisib-plus-gemcitabine-for-recurrent-pediatric-at-rt https://www.cancernetwork.com/view/paxalisib-gemcitabine-combination-dosed-in-first-patient-with-cns-tumor Wed, 09 Sep 26 00:00:00 -0400 https://www.cancernetwork.com/view/paxalisib-gemcitabine-combination-dosed-in-first-patient-with-cns-tumor https://www.genomeweb.com/cancer/colorectal/gnw-kazia-paxalisib-colorectal-cancer-20260904/ Fri, 04 Sep 26 00:00:00 -0400 https://www.genomeweb.com/cancer/colorectal/gnw-kazia-paxalisib-colorectal-cancer-20260904/